- CNBC•7 hours ago
The Fast Money Traders discuss if the pharmaceutical company will be acquired.
- Zacks•9 hours ago
Bristol-Myers Squibb Company (BMY) along with partner Ono Pharmaceutical Company, Ltd. announced that both the companies have signed a global patent license agreement with Merck & Co., Inc. (MRK) to settle all litigation related to Keytruda.
- Market Realist•10 hours ago
With rising sales of innovative products such as Eliquis, Opdivo, and its hepatitis C franchise, Bristol-Myers Squibb is expected to report a rise of over 20% in its 4Q16 earnings.
BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||49.15 - 50.31|
|52 Week Range||48.92 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||25.01|
|Dividend & Yield||1.56 (3.17%)|
|1y Target Est||N/A|